ONL Therapeutics Inc.
- Address
- 524 South Main Street
Sponsor Overview
Specializations
Retinal Degeneration and Age-related Macular Degeneration
ONL Therapeutics Inc. focuses on atrophic age-related macular degeneration, with particular attention to geographic atrophy and the preservation of retinal structure and visual function.
- Atrophic AMD
- Geographic atrophy
- Retinal disease
The sponsor’s clinical activity is centered on eye disease research intended to address progressive degeneration of the macula and related loss of central vision.
Ophthalmology and Vision Preservation
The research portfolio is rooted in ophthalmology, with interest in therapies for conditions that affect the retina, macula, and long-term visual acuity.
- Macular pathology
- Central vision impairment
- Degenerative eye disorders
Clinical work in this area reflects a therapeutic focus on slowing disease progression in chronic retinal disorders.
Geographic Atrophy Intervention Research
ONL Therapeutics is engaged in research related to geographic atrophy, a late-stage manifestation of AMD associated with progressive loss of retinal tissue.
- Progressive retinal atrophy
- Macular degeneration
- Chronic degenerative eye disease
This therapeutic domain is directed toward patients with advanced retinal damage and unmet ophthalmic needs.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of Xelafaslatide (ONL1204) in Geographic Atrophy Secondary to Age-related Macular Degeneration: A Phase 2 Randomized Controlled Trial |  Austria Czechia Germany Greece Hungary Italy Poland Portugal Spain | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 54 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases1 trial138 other sponsors
- 2.Ocular Physiological Phenomena1 trial6 other sponsors
Partnered Research Centres
54 centres- Address
- Azinhaga De Santa Comba, 3000-548 Coimbra
- Address
- Via Giovanni Battista Grassi 74, 20157 Milan
- Address
- Georg-Baumgarten-Strasse 3, Flughafen, 60549 Frankfurt
- Address
- Ostrovskeho 253/3, Smichov, 150 00 Prague
- Address
- Via Cherasco 15, 10126 Turin
Want to get in touch with this sponsor?
Send a question and we'll pass it on to ONL Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.